LIXTE BIOTECHNOLOGY HOLDINGS, INC. - Common Stock, par value $0.0001 per share (LIXT)

CUSIP: 539319301

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
2,666,933
Total 13F shares
17,340
Share change
+17,340
Total reported value
$101,452
Price per share
$5.88
Number of holders
5
Value change
+$101,452
Number of buys
5

Quarterly Holders Quick Answers

What is CUSIP 539319301?
CUSIP 539319301 identifies LIXT - LIXTE BIOTECHNOLOGY HOLDINGS, INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LIXTE BIOTECHNOLOGY HOLDINGS, INC. - Common Stock, par value $0.0001 per share (LIXT) as of Q2 2023

As of 30 Jun 2023, LIXTE BIOTECHNOLOGY HOLDINGS, INC. - Common Stock, par value $0.0001 per share (LIXT) was held by 5 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,340 shares. The largest 5 holders included GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, UBS Group AG, Tower Research Capital LLC (TRC), and WELLS FARGO & COMPANY/MN. This page lists 5 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.